Table 5 Adverse events (AE) considered possibly related to treatment and reported in ≥ 0.5% of patients (safety-evaluable population; N = 478)
AE | Number (%) of patients |
|---|---|
Total | 59 (12.3) |
Hypertension | 14 (2.9) |
Thrombosis | 9 (1.9) |
Anaemia | 5 (1.0) |
Injection site pain | 5 (1.0) |
Laboratory test abnormal* | 4 (0.8) |
Erythrocyte abnormal | 3 (0.6) |
Headache | 3 (0.6) |